Abstract
MBP-1, a cellular factor, appears to be involved in multiple functions, including transcriptional modulation, apoptosis and cell growth regulation. In this study, we have investigated the signaling pathway involved in MBP-1 mediated apoptotic cell death. Human carcinoma cells infected with a replication deficient adenovirus expressing MBP-1 (AdMBP-1) induced apoptosis, when compared with cells infected by replication-defective adenovirus (dl312) as a negative control. Transduction of MBP-1 in carcinoma cells releases cytochrome c from mitochondria into the cytosol leading to activation of procaspase-9, procaspase-3 and PARP cleavage. We previously observed that MBP-1 mediated apoptosis can be protected by Bcl-2, although MBP-1 does not share a homology with the BH domain of the Bcl-2 family member of proteins. To further understand the mechanism of MBP-1 mediated apoptosis, we examined whether MBP-1 modulates the Bcl-2 gene family. Our results demonstrated that human breast carcinoma cells infected with AdMBP-1 selectively reduced Bcl-xL mRNA and protein expression when compared with dl312 infected negative control cells. An in vitro transient reporter assay also suggested repression of the Bcl-x promoter activity by MBP-1. Additional studies indicated that MBP-1 modulates Ets family protein function, thereby downregulating Bcl-xL expression. Taken together, our results suggest that MBP-1 selectively represses Bcl-xL expression in MCF-7 cells and induces mitochondrial involvement in the apoptotic process.
Similar content being viewed by others
References
Ackermann EJ, Taylor JK, Narayana R, Bennett CF . 1999 J. Biol. Chem. 274: 11245–11252
Adams JM, Cory S . 1998 Science 281: 1322–1326
Antonsson B, Martinou JC . 2000 Exp. Cell Res. 256: 50–57
Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB . 1993 Cell 74: 597–608
Bossy-Wetzel E, Newmeyer DD, Green DR . 1998 EMBO J. 17: 37–49
Cai J, Yang J, Jones DP . 1998 Biochim. Biophys. Acta. 1366: 139–149
Chaudhury D, Miller DM . 1995 Biochemistry 34: 3438–3445
Chao DT, Korsmeyer SJ . 1998 Annu. Rev. Immunol. 16: 395–419
Chen HM, Boxer LM . 1995 Mol. Cell. Biol. 15: 3840–3847
Ealovega MW, McGinnis PK, Sumantran VN, Clarke MF, Wicha MS . 1996 Cancer Res. 56: 1965–1969
Feo S, Arcuri D, Piddini E, Passantino R, Giallongo A . 2000 FEBS Lett. 473: 47–52
Germain M, Affar EB, D'Amours D, Dixit VM, Salvesen GS, Poirier GG . 1999 J. Biol. Chem. 274: 28379–28384
Ghosh AK, Steele R, Ray RB . 1999 Mol. Cell. Biol. 19: 2880–2886
Ghosh AK, Majumder M, Steele R, Yaciuk P, Chrivia J, Ray R, Ray RB . 2000 J. Biol. Chem. 275: 7184–7188
Ghosh AK, Majumder M, Steele R, White RA, Ray RB . 2001 Mol. Cell. Biol. 21: 655–662
Giallongo A, Feo S, Moore R, Croce CM, Showe LC . 1986 Proc. Natl. Acad. Sci. USA 83: 6741–6745
Graham FL . 2000 Immunol. Today 21: 426–428
Green DR, Reed JC . 1998 Science 281: 1309–1312
Grillot DA, Gonzalez-Garcia M, Ekhterae D, Duan L, Inohara N, Ohta S, Seldin MF, Nunez Z . 1997 J. Immunol. 158: 4750–4757
Hatano E, Bradham CA, Stark A, Iimuro Y, Lemasters JJ, Brenner DA . 2000 J. Biol. Chem. 275: 11814–11823
Hu Y, Benedict MA, Wu D, Inohara N, Nunez G . 1998 Proc. Natl. Acad. Sci. USA 95: 4386–4391
Kharbanda S, Pandey P, Schofield L, Israels S, Roncinske R, Yoshida K, Bharti A, Yuan ZM, Saxena S, Weichselbaum R, Nalin C, Kufe D . 1997 Proc. Natl. Acad. Sci. USA 94: 6939–6942
Kim TH, Zhao Y, Barber MJ, Kuharsky DK, Yin XM . 2000 J. Biol. Chem. 275: 39474–39481
Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD . 1997 Science 275: 1132–1136
Li F, Srinivasan A, Wang Y, Armstrong RC, Tomaselli KJ, Fritz LC . 1997 J. Biol. Chem. 272: 30299–30305
Liu R, Page C, Beidler DR, Wicha MS, Nunez G . 1999a Am. J. Pathol. 155: 1861–1867
Liu T-J, El-Naggar AK, McDonnell TJ, Steck KD, Wang M, Taylor DL, Clayman GL . 1995 Cancer Res. 55: 3117–3122
Liu T-J, Wang M, Breau RL, Henderson Y, El-Naggar AK, Steck KD, Sicard MW, Clayman GL . 1999b Cancer Gene Ther. 6: 163–172
Liu X, Kim CN, Yang J, Jemmerson R, Wang X . 1996 Cell 86: 147–157
Mercatante DR, Bortner CD, Cidlowski JA, Kole R . 2001 J. Biol. Chem. 276: 16411–16417
Olopade OI, Adeyanju MO, Safa AR, Hagos F, Mick R, Thompson CB, Recant WM . 1997 Cancer J. Sci. Am. 3: 230–237
Ray RB . 1995 Cell Growth Differ. 6: 1089–1096
Ray RB, Meyer K, Steele R, Shrivastava A, Aggarwal BB, Ray R . 1998 J. Biol. Chem. 273: 2256–2259
Ray R, Miller DM . 1991 Mol. Cell. Biol. 11: 2154–2161
Ray RB, Sheikh MS, Fontana JF, Miller DM . 1994 Int. J. Oncol. 5: 1433–1436
Ray RB, Steele R, Seftor E, Hendrix M . 1995 Cancer Res. 55: 3747–3751
Ray R, Thomas S, Miller DM . 1989 Oncogene 4: 593–600
Reed JC . 1997 Cell 91: 559–562
Reed JC . 1998 Cancer J. Sci. Am. 4: S8–S14
Reed JC . 1999 J. Clin. Oncol. 17: 2941–2953
Reed JC, Jurgensmeier JM, Matsuyama S . 1998 Biochim. Biophys. Acta 1366: 127–137
Reeve JG, Xiong J, Morgan J, Bleehen NM . 1996 Br. J. Cancer 73: 1193–1200
Schmitt E, Cimoli G, Steyaert A, Bertrand R . 1998 Exp. Cell Res. 240: 107–121
Sevilla L, Aperlo C, Dulic V, Chambard JC, Boutonnet C, Pasquier O, Pognonec P, Boulukos KE . 1999 Mol. Cell. Biol. 19: 2624–2634
Shimizu S, Eguchi Y, Kamiike W, Waguri S, Uchiyama Y, Matsuda H, Tsujimoto Y . 1996 Oncogene 13: 21–29
Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissonnette RP, Green DR . 1992 Science 257: 212–214
Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, Wang H-G, Reed JC, Nicholson DW, Alnemri ES, Green DR, Martin SJ . 1999 J. Cell Biol. 144: 281–292
Steller H . 1995 Science 267: 1445–1449
Strasser A, O'Connor L, Dixit VM . 2000 Annu. Rev. Biochem. 69: 217–245
Subramaniun A, Miller DM . 2000 J. Biol. Chem. 275: 5958–5965
Susin SA, Zamzami N, Kroemer G . 1998 Biochim. Biophys. Acta 1366: 151–165
Thompson CB . 1995 Science 267: 1456–1462
Thornberry NA, Lazebnik Y . 1998 Science 281: 1312–1326
Tu Y, Renner S, Xu F, Fleishman A, Taylor J, Weisz J, Vescio R, Rettig M, Berenson J, Krajewski S, Reed JC, Lichtenstein A . 1998 Cancer Res. 58: 256–262
White RA, Adkison LR, Dowler LL, Ray RB . 1997 Genomics 39: 406–408
Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X . 1997 Science 275: 1129–1132
Yasushi F, Keita K, Hisao H, Keiko Y-T, Tadamitsu K . 1997 J. Clin. Invest. 99: 2898–2905
Zamzami N, Brenner C, Marzo I, Susin SA, Kroemer G . 1998 Oncogene 16: 2265–2282
Acknowledgements
This research was supported by grant CA52799 from the National Cancer Institute. We thank Linda Boxer, G Chinnadurai and Ranjan Sen for helpful suggestions. Authors thank G Chinnadurai for providing Bcl-2 antibody, Keiko Yamauchi-Takihara for providing Bcl-x promoter constructs, and Maria Trojanowska for providing synthetic Ets-TK construct and Ets-1 cDNA for our research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ghosh, A., Majumder, M., Steele, R. et al. MBP-1 mediated apoptosis involves cytochrome c release from mitochondria. Oncogene 21, 2775–2784 (2002). https://doi.org/10.1038/sj.onc.1205384
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205384
- Springer Nature Limited
Keywords
This article is cited by
-
Proteomic analysis of differentially expressed proteins in 5-fluorouracil-treated human breast cancer MCF-7 cells
Clinical and Translational Oncology (2014)
-
Hypoxia induces differential translation of enolase/MBP-1
BMC Cancer (2010)